Table 3 Characteristics of head and neck cancer survivors by severe pain
Variable | (−) Severe Pain | (+) Severe Pain1 | P-value6 | ||
|---|---|---|---|---|---|
N | (%) | N | (%) | ||
Age (years) | 0.069 | ||||
Mean ± Std.Dev | 61.8 ± 10.7 | 58.7 ± 9.6 | |||
Sex | 0.760 | ||||
Male | 362 | (92.8) | 28 | (7.2) | |
Female | 103 | (92.0) | 9 | (8.0) | |
Marital Status | 0.697 | ||||
Single or separated | 90 | (91.8) | 8 | (8.2) | |
Married or cohabiting | 374 | (92.8) | 29 | (7.2) | |
Not available | |||||
Education | 0.396 | ||||
No college degree | 203 | (91.4) | 19 | (8.6) | |
College graduate | 258 | (93.5) | 18 | (6.5) | |
Not available | |||||
Employment | 0.609 | ||||
Not employed or retired | 237 | (93.3) | 17 | (6.7) | |
Employed | 225 | (91.8) | 20 | (8.2) | |
Not available | |||||
Race | 0.768 | ||||
Non-Hispanic White | 422 | (92.7) | 33 | (7.3) | |
Other | 43 | (91.5) | 4 | (8.5) | |
Survivorship (years)2 | 0.439 | ||||
Average ± Std.Dev | 4.6 ± 4.4 | 5.2 ± 4.1 | |||
Survivorship | 0.392 | ||||
≤ 1 year | 133 | (94.3) | 8 | (5.7) | |
> 1 to ≤3 years | 105 | (92.9) | 8 | (7.1) | |
> 3 to ≤8 years | 134 | (92.4) | 11 | (7.6) | |
> 8 years | 93 | (90.3) | 10 | (9.7) | |
Site of HNC | 0.092 | ||||
Oropharynx | 245 | (91.4) | 23 | (8.6) | |
Oral cavity | 113 | (97.4) | 3 | (2.6) | |
Larynx | 48 | (88.9) | 6 | (11.1) | |
Other | 59 | (92.2) | 5 | (7.8) | |
Recurrent disease | 0.065 | ||||
Yes | 82 | (97.6) | 2 | (2.4) | |
No | 396 | (92.3) | 33 | (7.7) | |
Treatment3 | |||||
Chemotherapy | 261 | (89.4) | 31 | (10.6) | 0.001 |
Radiotherapy | 374 | (91.7) | 34 | (8.3) | 0.089 |
Surgery | 296 | (94.0) | 19 | (6.0) | 0.132 |
Single modality | 129 | (97.0) | 4 | (3.0) | 0.045 |
Multi modality | 338 | (91.4) | 32 | (8.6) | |
Comorbidities3 | |||||
Hypertension | 198 | (93.8) | 13 | (6.2) | 0.301 |
Herniated disc and radiculopathy | 96 | (89.7) | 11 | (10.3) | 0.227 |
Osteoarthritis | 55 | (87.3) | 8 | (12.7) | 0.121 |
Neuropathic pain | 47 | (85.5) | 8 | (14.5) | 0.049 |
Diabetes | 52 | (94.5) | 3 | (5.5) | 0.785 |
Coronary heart disease | 43 | (91.5) | 4 | (8.5) | 0.772 |
Emphysema and lung disease | 26 | (83.9) | 5 | (16.1) | 0.075 |
Rheumatoid arthritis | 29 | (93.5) | 2 | (6.5) | 1.000 |
Cerebrovascular disease | 19 | (90.5) | 2 | (9.5) | 0.671 |
Depression Risk4 | < 0.001 | ||||
No risk | 374 | (95.4) | 18 | (4.6) | |
Mild-moderate risk | 63 | (84.0) | 12 | (16.0) | |
Major risk | 24 | (77.4) | 7 | (22.6) | |
Not available | 7 | ||||
Analgesia Classification5 | 0.004 | ||||
No analgesic | 335 | (95.2) | 17 | (4.8) | |
Step 1 | 68 | (89.5) | 8 | (10.5) | |
Step 2 | 3 | (100.0) | 0 | (0.0) | |
Step 3 | 58 | (82.9) | 12 | (17.1) | |
Not available | 4 | ||||